People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CorVent Medical, Inc. | — | Healthtech | Series A | $13.7M | $15.8M | 2023 |
Mark S. Gelfand at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark S. Gelfand on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard S. Walsh | 1 | 1 |
| Jeremy S. Nelson | 1 | 1 |
| John S. O'Connor | 1 | 1 |
| John A. Ballantyne | 1 | 1 |
| Travis S. Murphy | 1 | 1 |
| John S. O'Mahony | 1 | 1 |
| Randy S. Schneider | 1 | 1 |
| Mark S. Tibbles | 1 | 1 |
| Murphy S. Travis | 1 | 1 |
| John S. Ballantyne | 1 | 1 |
| Mark Gelfand | 1 | 1 |
| Rob Faulkner | 1 | 1 |
| Lukas Geunther | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.